Whitnell & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Whitnell & Co's NVS Position: Q3 2019 in Review
Whitnell & Co sold out of Novartis (NVS) in Q3 2019, closing a stake of 200 shares — an estimated $18K sold.
Whitnell & Co first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $127K in Q3 2015. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.
- Whitnell & Co reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
- Whitnell & Co sold 200 Novartis shares in Q3 2019, an estimated $18K.
- Whitnell & Co first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
- Whitnell & Co's Novartis position peaked at $127K in Q3 2015.
- 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.
Based on Whitnell & Co's 13F filing for Q3 2019, filed 5 Nov 2019.